NCT06925100 - A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions

Primary Hypercholesterolemia or Mixed Hyperlipidemia

Interventions

DRUG

Bempedoic acid 180 mg tablet

180 mg tablet, once daily administered for 12 weeks

Trial Locations (3)

RECRUITING

Far Eastern Memorial Hospital, New Taipei City

RECRUITING

Linkou Chang Gung Memorial Hospital, Taoyuan District

RECRUITING

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City